Gen Incode
Oxford, GB · 2 known investors
GENinCode develops genetic and clinical testing products for cardiovascular disease and familial hypercholesterolemia, providing risk assessment and prediction to help physicians stratify patients and select treatment pathways. It works with healthcare providers including the NHS in the UK.